BWS Financial Initiates Coverage On Twist Bioscience with Sell Rating, Announces Price Target of $45

BWS Financial analyst Hamed Khorsand initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Sell rating and announces Price Target of $45.